M&A Deal Summary |
|
---|---|
Date | 2019-12-12 |
Target | Heartland Veterinary Partners |
Sector | Consumer Services |
Buyer(s) |
Gryphon Investors
Athyrium Capital Management |
Sellers(s) | Tyree & D Angelo Partners |
Deal Type | Secondary Buyout |
Advisor(s) | William Blair (Financial) Winston & Strawn (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1997 |
PE ASSETS | 8.9B USD |
Size | Mega |
Type | Sector Agnostic |
Gryphon Investors is a private equity firm focused on making $50 to $300 million of equity or equity-linked investments in middle-market companies. Target transaction situations include traditional buyouts, leveraged build-ups, and growth financings. Gryphon will consider both control and shared-control positions. Sectors of interest include business services, consumer, retail, automotive, chemicals, general manufacturing, healthcare, and hotels. Gryphon Investors was formed in 1997 and is based in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 55 of 81 |
Sector (Consumer Services) | 2 of 2 |
Type (Secondary Buyout) | 16 of 24 |
State (Illinois) | 4 of 7 |
Country (United States) | 55 of 80 |
Year (2019) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-09-30 |
ECG Management Consultants
Seattle, Washington, United States ECG Management Consultants, Inc. is a strategic consulting firm that is major healthcare forward, using knowledge and expertise built over the course of four decades to help clients see clearly where healthcare is going and to navigate toward success. ECG Management Consultants was founded in 1973 and is based in Seattle, Washington. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-01-23 |
Ncontracts
Brentwood, Tennessee, United States Ncontracts LLC provides risk, vendor, and compliance management software to a rapidly expanding customer base of more than 1,300 financial institutions located in all 50 states and U.S. territories. Ncontracts's powerful combination of software and services enables financial institutions to achieve their risk management and compliance goals with an integrated, user-friendly cloud-based solution suite that encompasses vendor risk, compliance risk, and enterprise risk management. |
Buy | - |
Category | Asset Manager |
---|---|
Founded | 2008 |
PE ASSETS | 3.7B USD |
Size | Large |
Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York City.
DEAL STATS | # |
---|---|
Overall | 37 of 44 |
Sector (Consumer Services) | 3 of 3 |
Type (Secondary Buyout) | 5 of 6 |
State (Illinois) | 3 of 3 |
Country (United States) | 34 of 39 |
Year (2019) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-06-16 |
ArisGlobal
Coral Gables, Florida, United States ArisGlobal is a visionary technology company that’s transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal’s LifeSphere drug development platform integrates cognitive computing technologies to automate the core functions of the product lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, the LifeSphere platform delivers actionable insights, boosts efficiency, ensures compliance, and lowers total cost of ownership through a multi-tenant SaaS model. ArisGlobal was founded in 1987 and is based in Coral Gables, Florida. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-06-19 |
Biora Therapeutics
San Diego, California, United States Progenity helps patients and their families Prepare for Life, with medically relevant health information starting before conception, through pregnancy and adulthood. Using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages. Progenity was founded in 2010 and is based in San Diego, California. |
Sell | - |
Tyree & D'Angelo Partners (TDP) is a private equity firm that focuses on control investments in lower middle-market companies. TDP seeks companies with less then $50 million in annual revenue and EBITDA of $1 to $5 million. Sectors of interest include healthcare, consumer, agriculture, and business services. TDP has a preference for Midwestern US-based companies, but will consider opportunities across the US and Canada. Tyree & D'Angelo Partners was formed in 2013 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Consumer Services) | 1 of 1 |
Type (Secondary Buyout) | 2 of 2 |
State (Illinois) | 2 of 2 |
Country (United States) | 2 of 2 |
Year (2019) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-06-01 |
Western Veterinary Partners
Denver, Colorado, United States Western Veterinary Partners acquires and supports veterinary practices and animal hospitals with the non-clinical business challenges they face by providing industry-proven non-clinical administrative support services. Western Veterinary Partners is based in Denver, Colorado. |
Buy | - |